Propanc Biopharma, Inc. Common Stock (PPCB) is a publicly traded the market company. As of September 4, 2026, PPCB trades at $1.04 with a market cap of $2.35M and a P/E ratio of 0.00. PPCB moved +1.86% today. Year to date, PPCB is -92.86%; over the trailing twelve months it is -97.94%. Its 52-week range spans $0.95 to $600.00. Rallies surfaces PPCB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for PPCB, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $1.04 |
| Market Cap | $2.35M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $600.00 |
| 52-Week Low | $0.95 |
| Volume | 2.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PPCB analyst coverage data. Average price target: $0.00.